Exelixis Inc (EXEL)
21.90
-0.22
(-0.99%)
USD |
NASDAQ |
May 03, 16:00
21.90
0.00 (0.00%)
After-Hours: 20:00
Exelixis Cash from Financing (Quarterly): -184.05M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -184.05M |
| December 31, 2023 | -206.17M |
| September 30, 2023 | -219.67M |
| June 30, 2023 | -124.79M |
| March 31, 2023 | 4.586M |
| December 31, 2022 | -2.003M |
| September 30, 2022 | -2.038M |
| June 30, 2022 | 4.422M |
| March 31, 2022 | 0.205M |
| December 31, 2021 | -17.99M |
| September 30, 2021 | -2.881M |
| June 30, 2021 | 8.724M |
| March 31, 2021 | -2.65M |
| December 31, 2020 | -18.69M |
| September 30, 2020 | -3.435M |
| June 30, 2020 | -5.148M |
| March 31, 2020 | 2.145M |
| December 31, 2019 | -3.00M |
| September 30, 2019 | 3.274M |
| June 30, 2019 | 7.053M |
| March 31, 2019 | 5.226M |
| December 31, 2018 | -1.144M |
| September 30, 2018 | 3.611M |
| June 30, 2018 | 7.478M |
| March 31, 2018 | -0.254M |
| Date | Value |
|---|---|
| December 31, 2017 | -0.713M |
| September 30, 2017 | 2.871M |
| June 30, 2017 | -100.22M |
| March 31, 2017 | -71.87M |
| December 31, 2016 | 15.77M |
| September 30, 2016 | -0.699M |
| June 30, 2016 | 2.504M |
| March 31, 2016 | -1.877M |
| December 31, 2015 | 6.882M |
| September 30, 2015 | 149.44M |
| June 30, 2015 | -3.89M |
| March 31, 2015 | -0.217M |
| December 31, 2014 | 0.13M |
| September 30, 2014 | -0.374M |
| June 30, 2014 | 0.449M |
| March 31, 2014 | 65.29M |
| December 31, 2013 | -0.214M |
| September 30, 2013 | -0.789M |
| June 30, 2013 | 0.109M |
| March 31, 2013 | -10.78M |
| December 31, 2012 | -0.371M |
| September 30, 2012 | 415.92M |
| June 30, 2012 | -0.578M |
| March 31, 2012 | 63.45M |
| December 31, 2011 | -0.155M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-219.67M
Minimum
Sep 2023
8.724M
Maximum
Jun 2021
-38.11M
Average
-2.766M
Median
Cash from Financing (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | -446.10M |
| Johnson & Johnson | 546.00M |
| Merck & Co Inc | -2.245B |
| Pfizer Inc | 5.442B |
| Legend Biotech Corp | 0.925M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 68.82M |
| Cash from Investing (Quarterly) | 111.79M |
| Free Cash Flow | 185.10M |
| Free Cash Flow Per Share (Quarterly) | 0.1657 |
| Free Cash Flow to Equity (Quarterly) | 50.63M |
| Free Cash Flow to Firm (Quarterly) | 50.63M |
| Free Cash Flow Yield | 2.67% |